Agreement signedPublished 24 Feb 2025
Inhibikase Therapeutics, Inc. /
CorHepta Pharmaceuticals, Inc.
Inhibikase Therapeutics, Inc. agrees to buy CorHepta Pharmaceuticals, Inc.
01 / BuyerInhibikase Therapeutics, Inc.
02 / TargetCorHepta Pharmaceuticals, Inc.
Source-verifiedWhat happened
Inhibikase Therapeutics, Inc. agreed to acquire CorHepta Pharmaceuticals, Inc. for $15.0 million, according to a filing dated Feb. 24, 2025.
The source
Everything on this page comes from the source below.
01
Source · Original source
Inhibikase Therapeutics, Inc. agrees to buy CorHepta Pharmaceuticals, Inc.
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly